Basic information Safety Supplier Related

H-ARG-GLN-OH HYDROCHLORIDE SALT

Basic information Safety Supplier Related

H-ARG-GLN-OH HYDROCHLORIDE SALT Basic information

Product Name:
H-ARG-GLN-OH HYDROCHLORIDE SALT
Synonyms:
  • H-ARG-GLN-OH HCL
  • H-ARG-GLN-OH HYDROCHLORIDE SALT
  • H-Arg-Gln-OH
  • L-Glutamine, L-arginyl-
  • (S)-5-Amino-2-((S)-2-amino-5-guanidinopentanamido)-5-oxopentanoic acid
  • Arg-Gln
  • Arginyl-Glutamine
CAS:
2483-17-2
MF:
C11H22N6O4
MW:
302.33
Mol File:
2483-17-2.mol
More
Less

H-ARG-GLN-OH HYDROCHLORIDE SALT Chemical Properties

storage temp. 
-15°C
Sequence
Arg-Gln
More
Less

H-ARG-GLN-OH HYDROCHLORIDE SALT Usage And Synthesis

Uses

Arginyl-Glutamine is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].

Definition

ChEBI: Arg-Gln is a dipeptide formed from L-arginyl and L-glutamine residues. It has a role as a metabolite.

in vivo

Arginyl-Glutamine (1-5 g/kg/day as a hydrochloride salt; i.p.; twice daily) dramatically inhibits retinal neovascularization in the mouse oxygen-induced retinopathy (OIR) model[1].

Animal Model:C57BL6/J mouse pups, oxygen-induced retinopathy (OIR) model[1]
Dosage:1.0, 2.5, or 5 g/kg per day
Administration:Intraperitoneal injection, twice daily
Result:Significantly decreased preretinal nuclei. Reduced neovascular tufts and vascular leakage in retinal vessels. Reduced preretinal neovascularization by 82% ± 7% and reduced VEGF mRNA by 64% ± 9% at 5 g/kg per day.

References

[1] Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3151-5. DOI:10.1167/iovs.05-1473

H-ARG-GLN-OH HYDROCHLORIDE SALTSupplier

GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Email
ymbetter@glbiochem.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Nanjing Peptide Biotech Ltd.
Tel
025-58361106-805 15951641583
Email
zhao.xu@njpeptide.com